CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Research and development spending
3Y CAGR
+59.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $116.64M | +42.1% |
| 2024 | $82.10M | +79.5% |
| 2023 | $45.75M | +57.6% |
| 2022 | $29.03M | +58.5% |
| 2021 | $18.32M | - |